Are There Advances in Next Generation Sequencing for CLL?
From our recent CLL Global Research Foundation Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Constantine Tam from Monash University in Melbourne.
Is CAR T-Cell Therapy Becoming Mainstream for CLL Patients?
From our recent CLL Global Research Foundation Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Constantine Tam from Monash University in Melbourne.
How Do BTK Degraders Affect the Tumor Cell Microenvironment in CLL?
From our recent CLL Global Research Foundation Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Constantine Tam from Monash University in Melbourne.
Are There Therapies to Maintain UMRD Status in CLL Patients?
From our recent CLL Global Research Foundation Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Constantine Tam from Monash University in Melbourne.
Treatment Updates for Patients with TP53 and 17p Deletion
From our recent CLL Global Research Foundation Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Constantine Tam from Monash University in Melbourne.
CLL Research Highlights from ASH 2024 | Dr. Constantine Tam
From our recent CLL Global Research Foundation Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Constantine Tam from Monash University in Melbourne.
CLL Global Virtual Town Hall: January 30, 2025
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.